Thomas Hutson, DO, PharmD, discusses key takeaways from the phase 3 CLEAR trial evaluating lenvatinib plus pembrolizumab in patients with advanced renal cell carcinoma.

Neuropathy, skin rash, and hyperglycemia following enfortumab vedotin treatment were associated with improved PFS in ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") , a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and CEO, Dr. Amit Kumar, was featured ...

A Kerry family are pleading for funds to travel to the US in May for maintenance cancer treatment which will give their ...

The Hendrix College Office of Engaged Learning has announced five Odyssey Professorships awarded to seven members of the ...

High prostate-specific antigen levels before High-Intensity Focused Ultrasound were linked to higher recurrence and treatment failure in intermediate-risk prostate cancer.

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Theratechnologies Inc. ("Theratechnologies" or the "Company") , a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

Successful petitions to receive compassionate early release from federal prisons due to health issues are rare. They are even ...

Penn State women's volleyball coach Katie Schumacher-Cawley has agreed to a contract extension through the 2030 season two months after leading the Nittany Lions to the national championship and days ...

The Karni Sena also protested against Apoorva's event and warned the government and the event organisers to take steps and ...